{"abstract": "Biogen Idec shares moved higher Friday on news that the Federal Trade Commission has approved activist investor Carl C. Icahn to purchase more of the company\u2019s shares, MarketWatch reported. Stock in the biotech company rose 5 percent to $62.89, a 52-week high.", "web_url": "https://dealbook.nytimes.com/2007/08/24/icahn-is-cleared-for-biogen-move/", "snippet": "", "lead_paragraph": "Biogen Idec shares moved higher Friday on news that the Federal Trade Commission has approved activist investor Carl C. Icahn to purchase more of the company\u2019s shares, MarketWatch reported. Stock in the biotech company rose 5 percent to $62.89, a 52-week high.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Icahn Is Cleared for Biogen Move", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-08-24T22:21:06+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/b15b8dbc-5f65-5a4d-9d13-a9acffa44984", "word_count": 113, "uri": "nyt://article/b15b8dbc-5f65-5a4d-9d13-a9acffa44984"}